If you're looking for cheap dividend stocks, these three names should be on your radar.
Sock these in your Roth IRA and you could be getting yields over 10% in a decade!
Short-term disappointments have tossed these three stand-out stocks on the discount rack.
These three dividend aristocrats are either yielding a ton, growing a ton, or both!
Let's look at the challenges and opportunities facing these Big Pharma stocks to see which is most attractive now.
Inherent advantages in the healthcare system for drugmakers are fueling soaring drug prices.
A high-profile failure in lung cancer patients punished Bristol-Myers Squibb's invetors and rewarded Merck & Co.'s investors.
If you buy and hold stocks with these three traits, you can catch these fat yields, too!
Looking for inexpensive stocks to ride an aging demographic trend? These five Big Pharma stocks are trading at steep discounts.
Don't blink, otherwise you could miss another innovative cancer drug hitting pharmacy shelves.